• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ZIMMER BIOMET, INC. G7 LONGEVITY NEUTRAL 36MM F; PROSTHESIS, HIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ZIMMER BIOMET, INC. G7 LONGEVITY NEUTRAL 36MM F; PROSTHESIS, HIP Back to Search Results
Catalog Number 20103606
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Pain (1994); Swelling/ Edema (4577); Bursitis (4832)
Date of Event 04/26/2023
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported a patient received a cortisone injection approximately three months post implantation for lateral hip pain and trochanteric bursitis.Then again one year post implantation due to mild pain, moderate difficulties with adl¿s, snapping sensation and difficulty sleeping.The patient was prescribed a corticosteroid injection in the right trochanteric bursa, voltaren gel and a prescription for pt, possibly dry needling.Attempts have been made and no further information is available.
 
Additional Manufacturer Narrative
(b)(4).D10: cat #: 010000664, g7 pps ltd acet shell 54f, lot #: r7301744a.Cat #: 192113, echo por fmrl lat nc 13x145mm, lot #: 213200.Cat #: 00625006535, bone scr 6.5x35 self-tap, lot #: 65459622.Cat #: 650-0661, delta ceramic fem hd 36/0mm, lot #: 3128005.Bursitis is the inflammation or irritation of the bursae (the fluid filled sac that cushions the joint) and is typically caused by repetitive motion, overuse, and pressure to the bursae.Bursitis is a very common condition that can impact any of the joints and can last for a short duration or years.Symptoms the patient can experience include pain, tenderness, swelling, stiffness, decrease in movement, and/or redness at or around the joint that is involved.Conservative treatment consists of over the counter (otc) medications pain relievers and anti-inflammatories, rest, ice, elevation, and applying pressure wraps.If conservative treatments fail, physical therapy, aspiration, arthroscopy, or steroid injections may be necessary.The complaint indicates that postop bursitis developed and required medical intervention for treatment.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
G7 LONGEVITY NEUTRAL 36MM F
Common Device Name
PROSTHESIS, HIP
Manufacturer (Section D)
ZIMMER BIOMET, INC.
1800 w. center st.
warsaw IN 46580
Manufacturer (Section G)
ZIMMER BIOMET, INC.
1800 w. center st.
warsaw IN 46580
Manufacturer Contact
jennifer rapsavage
56 e. bell dr.
warsaw, IN 46582
5745260384
MDR Report Key19222871
Report Number0001822565-2024-01449
Device Sequence Number15189064
Product Code LPH
UDI-Device Identifier00889024518759
UDI-Public(01)00889024518759(17)370619(10)65502075
Combination Product (Y/N)N
Initial Reporter StateCO
Initial Reporter CountryUS
PMA/510(K) Number
K190660
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2023
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Study,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 05/01/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue Number20103606
Device Lot Number65502075
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/09/2024
Initial Report FDA Received Date05/01/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured06/20/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient SexFemale
Patient Weight90 KG
Patient RaceWhite
-
-